Dr. Dinesh Khanna

We've received very touching #sclerodermastories from patients & family. Read them all at the link below. Please consider supporting the Michigan Medicine Scleroderma Program on #GivingBlueday 11/27/18, at medicine.umich.edu/dept/intmed/di… … #medicineneedsvictors #victorsinthehouse #Rheum

Exciting data on CAR-T from @Worldsclerofnd meeting in Athens in #scleroderma. Complete B cell depletion in tissue, response in RNA pol 3 Ab, and ++large clinical response. Clinical trials starting comparing CAR-T to standard of care therapies with Novartis and BMS.

Join me and Dr Monalisa Ghosh to get an update on cell therapy in # scleroderma on Friday, December 12 - 2:00 p.m. ET. Sponosred by @scleroderma us02web.zoom.us/webinar/regist…

SLS 3 is published. acrjournals.onlinelibrary.wiley.com/doi/10.1002/ac… 1. Upfront MMF+PFD vs. MMF+PLA 2. Underpowered due to Covid 3. No difference in primary end- FVC% 4. ⬆️AE and discont with MMF+PFD What else did we learn? A. Trends favor MMF+PFD in PROs and in HRCT QILD B. Need well powered trials

✨How can we better understand and treat fibrotic diseases? Meet Dr. Dinesh Khanna at #ECM2026. @sclerodermaUM He is a Professor of Medicine and Director of the University of Michigan (@UMich) Scleroderma Program , pioneering precision research in #scleroderma and #fibrosis.

📢 There were “clinical improvements in lung function and skin thickness in patients with severe refractory #SSc, with 96% remaining off SSc-directed therapies during the follow up,” said Dr. Dinesh Khanna @sclerodermaUM. healio.com/news/rheumatol…

A lot of enthusiasm about CAR-T therapy in #scleroderma. Data from Phase 1 trial sclerodermanews.com/news/car-t-cel…

Proud moment. Neha Khanna, 2nd year undergraduate at UM presenting first author poster at #ACR25. Thanks to her mentor ⁦⁦@elizatsou⁩ and ⁦@UMIntMed⁩

📢 “Preliminary meaningful improvement in #lung function and #skin thickness was observed” in patients with #SSc who received #CARTcelltherapy, said Dr. Dinesh Khanna @sclerodermaUM.   Read the full story from #ACR25 here 👇 healio.com/news/rheumatol…

#ACR2025. Exciting data on CAR-T in SSc. Oct 26: Efficacy and Safety of BMS-986353, a CD19-Directed Chimeric Antigen Receptor T Cell Therapy: Phase 1 Trial in SSc Oct 27: RESET-SSc: Clinical Trial Evaluating Rese-cel Autologous 4-1BB CD19-CAR T Cell Therapy in Phase 1 in SSc

🫁Better understand key characteristics and diverse subtypes of fibrosing #interstitiallungdisease with our NEW CE #Webinar Series! Register Now: ow.ly/WJSc50X5a8q @sclerodermaUM @DrBernstein #Rheumatology #rheumatologists #InterstitialLungDisease #LungDisease #CME

Interested in a career in scleroderma and related disorders? Join one of the largest programs with robust clinical research and trials. We are actively recruiting! @UMIntMed nejmcareercenter.org/job/920859/div… 📷

Join me and @Kahlenberglab today at 11 am ET ecm-congress.org/ecm-pharmacolo… Thanks to @Nordic_Bio for inviting us!

Interested in a position at U-M scleroderma program? Expertise in analyzing omics data. We are leading center in clinical trials and one of the largest scleroderma program. careers.umich.edu/job_detail/264…

Join us today at 12 pm for Grand Rounds on "Systemic Sclerosis: An Update" presented by @sclerodermaUM, professor in the Division of Rheumatology. Learn more: medschool.umich.edu/departments/in…

Delighted to present @UMIntMed grand rounds today at noon ET. Systemic Sclerosis- an update! Join at umich.zoom.us/j/97732438261 Password:  606879

DID YOU KNOW? >30% of Systemic Sclerosis pts present without Raynauds!. Data from 2 large US cohorts, of SSc dx with puffy fingers/hands or other symptoms. Such patients presented with more severe skin and musculoskeletal disease. buff.ly/t6mFdB9

Our first person Susan Chrysogelos who received CAR-T #scleroderma @UMIntMed @srfcure @scleroderma michiganmedicine.org/health-lab/scl… #findcureforscleroderma

Bringing rheumatology closer to haematology. CAR-T therapy is showing tremendous promise in autoimmune conditions esp difficult to treat cases. #eular2025

“Normal” CPK by race and gender. ⁦@docrota⁩ ⁦@FloridaRheums⁩